Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization

Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization

Parkinson's disease is the second most frequent neurodegenerative disease, representing a significant medical and socio-economic problem. Modern medicine still has no answer to the question of why Parkinson's disease develops and whether it is possible to develop an effective system of pre...

Full description

Bibliographic Details
Main Authors: Oxana P. Trifonova, Dmitri L. Maslov, Elena E. Balashova, Guzel R. Urazgildeeva, Denis A. Abaimov, Ekaterina Yu. Fedotova, Vsevolod V. Poleschuk, Sergey N. Illarioshkin, Petr G. Lokhov
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Diagnostics
Subjects:
Parkinson's disease
diagnostics
clinical test
metabolomics
biomarker
pharmacotherapy personalization
Online Access:https://www.mdpi.com/2075-4418/10/5/339

Internet

https://www.mdpi.com/2075-4418/10/5/339

Similar Items